To determine the relative contribution of PLA2G7 to tissue wasting in cancer, we generated C26 cells with a stable knock‐down for Pla2g7 (C26‐shPla2g7), through the transfection of a plasmid expressing a shRNA against Pla2g7 and subsequent selection of transfected cells. The gene discussed is PLA2G7; the disease is cancer.